1. Home
  2. GTE vs GLSI Comparison

GTE vs GLSI Comparison

Compare GTE & GLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gran Tierra Energy Inc.

GTE

Gran Tierra Energy Inc.

N/A

Current Price

$9.86

Market Cap

273.7M

Sector

Energy

ML Signal

N/A

Logo Greenwich LifeSciences Inc.

GLSI

Greenwich LifeSciences Inc.

HOLD

Current Price

$16.48

Market Cap

244.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTE
GLSI
Founded
2003
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
244.7M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
GTE
GLSI
Price
$9.86
$16.48
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$50.00
AVG Volume (30 Days)
1.5M
111.5K
Earning Date
05-01-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$374,460,000.00
N/A
Revenue This Year
$1.39
N/A
Revenue Next Year
$2.84
N/A
P/E Ratio
N/A
N/A
Revenue Growth
41.99
N/A
52 Week Low
$3.09
$7.78
52 Week High
$11.52
$34.10

Technical Indicators

Market Signals
Indicator
GTE
GLSI
Relative Strength Index (RSI) 66.09 51.01
Support Level $7.02 $16.52
Resistance Level $11.52 $29.89
Average True Range (ATR) 0.70 1.21
MACD 0.07 0.37
Stochastic Oscillator 43.84 59.56

Price Performance

Historical Comparison
GTE
GLSI

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. The majority of its revenue comes from operations in Colombia.

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.

Share on Social Networks: